OMDM-5
CAS No. 616884-66-3
OMDM-5( —— )
Catalog No. M26348 CAS No. 616884-66-3
OMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
|
10MG | 447 | Get Quote |
|
25MG | 714 | Get Quote |
|
50MG | 1017 | Get Quote |
|
100MG | 1368 | Get Quote |
|
500MG | 2673 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOMDM-5
-
NoteResearch use only, not for human use.
-
Brief DescriptionOMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM).
-
DescriptionOMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM). OMDM-5 is a selective anandamide cellular uptake (ACU) inhibitor(Ki = 4.8 μM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number616884-66-3
-
Formula Weight432.649
-
Molecular FormulaC26H44N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCC\C=C/CCCCCCCC(=O)NNCc1ccc(O)c(OC)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhao R, Zhao X, Gao X. Molecular-level insights into intrinsic peroxidase-like activity of nanocarbon oxides. Chemistry. 2015 Jan 12;21(3):960-4.
molnova catalog
related products
-
Cardiogenol C hydroc...
Cardiogenol C hydrochloride is a cardiomyogenesis inducer in embryonic stem cells.
-
LY2828360
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100000 nM respectively).
-
Fatostatin
Fatostatin ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.